Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of this study is to compare the affects of aripiprazole and olanzapine on weight change.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
• Collaborator: Otsuka America Pharmaceutical
• Treatments: Aripiprazole; Olanzapine

Criteria

Inclusion Criteria:

• Adult patients diagnosed with schizophrenia or schizoaffective disorder who are currently taking olanzapine.